From The Hindu BusinessLine
Center-Right Owned by The Hindu Group (Kasturi & Sons)Biocon Q2 PAT drops 51%, delayed shipments weigh on margins
What's behind this
Biocon's net profit for the second quarter fell 57.3% to ₹56.7 crore. In the same quarter, total income rose to ₹4,423.4 crore, while total expenses increased to ₹4,361.9 crore.
AI-generated overview from 2 outlets. It summarises their reporting and adds no reporting of its own.
What each side is saying
One outlet's own words from each side of the spectrum. Quoted, not summarised.
-
right · 1 outlet
The generics segment reported a 10% increase in revenue to ₹774 crore, while the Biosimilars segment grew 3% to ₹2,809 crore
RSS excerpt
The generics segment reported a 10% increase in revenue to ₹774 crore, while the Biosimilars segment grew 3% to ₹2,809 crore
